PAL2 for High Blood Pressure

"The requirements for inclusion in this clinical trial dictate that patients must be between 18 and 95 years old."

"Affirmative. According to the online records of clinicaltrials.gov, this trial initiated recruitment on November 18th 2022 and is still ongoing as of December 13th 2022. The study demands 500 volunteers from a single medical centre."

"Affirmative. Clinicaltrials.gov clearly displays that this medical trial, which initially launched on November 18th 2022, is actively recruiting applicants. In total, 500 patients are needed to fill one clinical site."

"This clinical trial, which is set to span over a period of 12 months, will assess the efficacy of PAL2 in reducing systolic Blood Pressure. Secondary objectives include evaluating Population Reach - assessed by measuring number and percentage of screened patients who meet inclusion criteria for ACHIEVE HTN; assessing Diastolic BP change from baseline to 12 months; and determining success rate of attaining Blood Pressure control (<130/80mmHg) via lifestyle modifications together with PAL2 intervention sans medication use."

"500 individuals with unidentified illnesses aged 18 to 95 are required for this clinical trial. Applicants should be Black/African American, have participated in a Detroit-area event, possess systolic BP of 130–139 mm Hg and diastolic BP below 90 mm Hg, not taking medications for hypertension (untreated), 10-year cardiovascular risk lower than 10% according to ASCVD calculator (most likely under 50 or 55 years old) and baseline home systolic BP from 120 to 159 mm Hg as well as diastolic BP less than 100 mm Hg."